04073681-a834-4f45-91c5-224b608b30e6

SPL v3
SPL
SPL Set ID 04073681-a834-4f45-91c5-224b608b30e6
Route
oral
Published
Effective Date 2022-10-31
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
mesalamine (0.375 g)
Inactive Ingredients
ethylcellulose (10 mpa.s) hypromellose 2910 (5 mpa.s) methacrylic acid - methyl methacrylate copolymer (1:1) talc triethyl citrate fd&c blue no. 1 gelatin water sodium lauryl sulfate titanium dioxide ferrosoferric oxide potassium hydroxide propylene glycol shellac sucrose starch, corn

Identifiers & Packaging

Pill Appearance
Imprint: 452 Shape: capsule Color: blue Size: 24 mm Score: 1
Marketing Status
anda active Since 2021-08-13

Description

Mesalamine Extended-Release Capsules, 0.375 g 120 capsules NDC 70771-1625-7 Rx only


Medication Information

Description

Mesalamine Extended-Release Capsules, 0.375 g 120 capsules NDC 70771-1625-7 Rx only

Package Label.principal Display Panel

Mesalamine Extended-Release Capsules, 0.375 g

120 capsules

NDC 70771-1625-7

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

Mesalamine Extended-Release Capsules, 0.375 g

120 capsules

NDC 70771-1625-7

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)